Source: Basic and Clinical Pharmacology and Toxicology. Unidade: FMRP
Subjects: ADIPONECTINA, BIOMARCADORES, PRESSÃO SANGUÍNEA, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, Ana Paula C. de et al. Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension. Basic and Clinical Pharmacology and Toxicology, v. 117, n. 1, p. 65-72, 2015Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12368. Acesso em: 21 maio 2024.APA
Faria, A. P. C. de, Modolo, R., Sabbatini, A. R., Barbaro, N. R., Corrêa, N. B., Brunelli, V., et al. (2015). Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension. Basic and Clinical Pharmacology and Toxicology, 117( 1), 65-72. doi:10.1111/bcpt.12368NLM
Faria APC de, Modolo R, Sabbatini AR, Barbaro NR, Corrêa NB, Brunelli V, Tanus-Santos JE, Fontana V, Moreno H. Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 1): 65-72.[citado 2024 maio 21 ] Available from: https://doi.org/10.1111/bcpt.12368Vancouver
Faria APC de, Modolo R, Sabbatini AR, Barbaro NR, Corrêa NB, Brunelli V, Tanus-Santos JE, Fontana V, Moreno H. Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 1): 65-72.[citado 2024 maio 21 ] Available from: https://doi.org/10.1111/bcpt.12368